|
26 Companies |
|
51 Products |
|
51 Products |
|
56 Mechanisms of Action |
|
3 Trials |
|
839 News |
|
| «12...567891011121314151617» |
- Enrollment change: To Study Polycystic Ovary Syndrome in Taiwanese Women (clinicaltrials.gov) - Jun 13, 2013
P=N/A, N=390, Completed, Sponsor: Taipei Medical University WanFang Hospital
N=300 --> 390
- Trial completion: To Study Polycystic Ovary Syndrome in Taiwanese Women (clinicaltrials.gov) - Jun 13, 2013
P=N/A, N=390, Completed, Sponsor: Taipei Medical University WanFang Hospital
N=300 --> 390 Recruiting --> Completed
- New P4 trial: GH and Cardiovascular Risk Factors (clinicaltrials.gov) - Jun 11, 2013
P4, N=32, Recruiting, Sponsor: VU University Medical Center
- Trial completion: Vitamin D and Omega-3 Inhibit Metabolic Syndrome (clinicaltrials.gov) - Jun 11, 2013
P3, N=40, Completed, Sponsor: University of Guelph
Recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| lemon balm extract (ALS-L1023) / Hanmi, AngioLab
New P3 trial: Efficacy and Safety Study of ALS-L1023 in Patients With Abdominal Obesity of Metabolic Syndrome (clinicaltrials.gov) - Jun 5, 2013
P3, N=400, Recruiting, Sponsor: Hanmi Pharmaceutical Company Limited
- Trial completion: ButCoIns - Metabolic Effects of Resistent Starch and Arabinoxylans in Subjects With Metabolic Syndrome (clinicaltrials.gov) - Jun 5, 2013
P=N/A, N=22, Completed, Sponsor: Aarhus University Hospital
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Enrollment closed: The Autonomic Nervous System and the Metabolic Syndrome (clinicaltrials.gov) - May 23, 2013
P=N/A, N=50, Active, not recruiting, Sponsor: Vanderbilt University
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Enrollment change: STRRIDE2: Effects of Resistance and Aerobic Exercise on Cardiovascular Health (clinicaltrials.gov) - May 22, 2013
P2, N=261, Completed, Sponsor: Duke University
Recruiting --> Active, not recruiting N=160 --> 261
- fenofibrate nanoparticle formulation / Generic mfg., pioglitazone / Generic mfg., fenofibrate / Generic mfg.
Enrollment closed: Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation (clinicaltrials.gov) - May 20, 2013
P=N/A, N=300, Active, not recruiting, Sponsor: Department of Veterans Affairs
N=160 --> 261 Recruiting --> Active, not recruiting
- ezetimibe / Generic mfg.
New P3 trial: Effects of Selective Inhibition of Cholesterol Absorption With Ezetimibe on Intestinal Cholesterol Homeostasis in Dyslipidemic Men With Insulin-resistance - a Pilot Study (clinicaltrials.gov) - May 6, 2013
P3, N=20, Recruiting, Sponsor: Laval University
- Trial completion: Prebiotics as a Means to Modulate Gut Fermentation, Metabolism, Appetite and Cognition (clinicaltrials.gov) - May 6, 2013
P0, N=40, Completed, Sponsor: Lund University
Recruiting --> Active, not recruiting Recruiting --> Completed
- Trial completion: Role of Colonic Events on Metabolism and Appetite Control: A Synbiotic Approach (clinicaltrials.gov) - May 6, 2013
P0, N=21, Completed, Sponsor: Lund University
Recruiting --> Completed Recruiting --> Completed
- || New P3 trial: The Organ Protection of Astragalus in Subjects With Metabolic Syndrome (clinicaltrials.gov) - May 5, 2013
P3, N=420, Recruiting, Sponsor: LanZhou University
- Enrollment change: TERMSINFAT: Testosterone Replacement in Metabolic Syndrome and Inflammation (clinicaltrials.gov) - May 4, 2013
P4, N=70, Recruiting, Sponsor: University of Roma La Sapienza
Recruiting --> Completed N=45 --> 70
- Enrollment open: TERMSINFAT: Testosterone Replacement in Metabolic Syndrome and Inflammation (clinicaltrials.gov) - May 4, 2013
P4, N=70, Recruiting, Sponsor: University of Roma La Sapienza
N=45 --> 70 Completed --> Recruiting
- metformin / Generic mfg.
Enrollment change: MVENT: Metformin in Preventing Androgen Deprivation Therapy Induced Insulin Resistance and Metabolic Syndrome (clinicaltrials.gov) - May 2, 2013
P2, N=28, Active, not recruiting, Sponsor: Western Sydney Local Health District
Completed --> Recruiting N=43 --> 28
- metformin / Generic mfg.
Enrollment closed: MVENT: Metformin in Preventing Androgen Deprivation Therapy Induced Insulin Resistance and Metabolic Syndrome (clinicaltrials.gov) - May 2, 2013
P2, N=28, Active, not recruiting, Sponsor: Western Sydney Local Health District
N=43 --> 28 Recruiting --> Active, not recruiting
- Enrollment change: A Study of the Function of Hormones Present In Taste Buds (clinicaltrials.gov) - Apr 24, 2013
P=N/A, N=300, Completed, Sponsor: National Institute on Aging (NIA)
Recruiting --> Active, not recruiting N=40 --> 300
- | metformin / Generic mfg., pioglitazone / Generic mfg.
Enrollment change: Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance (clinicaltrials.gov) - Apr 21, 2013
P2, N=28, Completed, Sponsor: Mayo Clinic
N=40 --> 300 N=49 --> 28
- eplerenone / Generic mfg.
Trial completion: MetSyn: Effect of Eplerenone on Endothelial Function in Metabolic Syndrome (clinicaltrials.gov) - Apr 15, 2013
P3, N=42, Completed, Sponsor: University of Erlangen-N
N=49 --> 28 Recruiting --> Completed
- Enrollment change: OBEFITT: Evaluation of the Impact of Physical Reconditioning Associated With Specific Nutritional Supplementation in Obese Patients Suffering From Metabolic Syndrome (clinicaltrials.gov) - Apr 14, 2013
P=N/A, N=100, Recruiting, Sponsor: University Hospital, Rouen
Recruiting --> Completed N=80 --> 100
- Trial completion: Isocaloric Dietary Interventions for Insulin Resistance and the Metabolic Syndrome (clinicaltrials.gov) - Apr 8, 2013
P=N/A, N=42, Completed, Sponsor: Rockefeller University
N=80 --> 100 Recruiting --> Completed
- Trial completion: Weight and Metabolic Effects of an Almond Enriched Hypocaloric, Low Fat Diet on Overweight and Obese Persons (clinicaltrials.gov) - Mar 25, 2013
P1/2, N=123, Completed, Sponsor: Temple University
Recruiting --> Completed Active, not recruiting --> Completed
- || New P2/3 trial: Efficacy and Safety of Chungkookjang on Improvement of Metabolic Syndrome (clinicaltrials.gov) - Mar 12, 2013
P2/3, N=120, Recruiting, Sponsor: Chonbuk National University Hospital
- Trial completion: Prevalence of Metabolic Syndrome in Atahualpa (clinicaltrials.gov) - Mar 6, 2013
P=N/A, N=517, Completed, Sponsor: Hospital Cl
Active, not recruiting --> Completed Recruiting --> Completed
- Trial completion, MRI: SURFER: Quantification of Liver Iron Overload and Steatosis Using Magnetic Resonance Imaging (clinicaltrials.gov) - Mar 6, 2013
P=N/A, N=250, Completed, Sponsor: Rennes University Hospital
Recruiting --> Completed Recruiting --> Completed
- Enrollment closed: VitD: Vitamin D Supplementation and Metabolism in Vitamin D Deficient Elderly (clinicaltrials.gov) - Feb 20, 2013
P=N/A, N=200, Active, not recruiting, Sponsor: Baltimore VA Medical Center
Recruiting --> Completed Recruiting --> Active, not recruiting
- ||| vardenafil / Generic mfg.
Trial completion: REVITALISE: Therapeutic Effectiveness of Vardenafil in Patients With Erectile Dysfunction and Metabolic Syndrome in Daily Clinical Practice (clinicaltrials.gov) - Feb 18, 2013
P=N/A, N=2289, Completed, Sponsor: Bayer
Recruiting --> Active, not recruiting Recruiting --> Completed
- Norditropin (somatropin) / Novo Nordisk
Trial withdrawal: Low Dose Growth Hormone Treatment in Subjects With Metabolic Syndrome. (clinicaltrials.gov) - Feb 17, 2013
P=N/A, N=0, Withdrawn, Sponsor: Oregon Health and Science University
Recruiting --> Completed Not yet recruiting --> Withdrawn
- Norditropin (somatropin) / Novo Nordisk
Trial initiation date: Low Dose Growth Hormone Treatment in Subjects With Metabolic Syndrome. (clinicaltrials.gov) - Feb 17, 2013
P=N/A, N=0, Withdrawn, Sponsor: Oregon Health and Science University
Not yet recruiting --> Withdrawn Initiation date: Oct 2008 --> Oct 2010
- Norditropin (somatropin) / Novo Nordisk
Enrollment change: Low Dose Growth Hormone Treatment in Subjects With Metabolic Syndrome. (clinicaltrials.gov) - Feb 17, 2013
P=N/A, N=0, Withdrawn, Sponsor: Oregon Health and Science University
Initiation date: Oct 2008 --> Oct 2010 N=12 --> 0
- Enrollment change: Combination of Insulin Sensitizer and Leptin as Treatment for the HAART -Induced Metabolic Syndrome (clinicaltrials.gov) - Feb 17, 2013
P2, N=15, Completed, Sponsor: Beth Israel Deaconess Medical Center
N=12 --> 0 N=44 --> 15
- Trial completion: Combination of Insulin Sensitizer and Leptin as Treatment for the HAART -Induced Metabolic Syndrome (clinicaltrials.gov) - Feb 17, 2013
P2, N=15, Completed, Sponsor: Beth Israel Deaconess Medical Center
N=44 --> 15 Active, not recruiting --> Completed
- Clinical: Beneficial Effects of Exercise and Healthy Diets on Muscle and Adipose Tissue (clinicaltrials.gov) - Feb 14, 2013
P=N/A, N=115, Not yet recruiting, Sponsor: University of Chile
- Bydureon (exenatide XR once-weekly) / AstraZeneca
New P3 trial: TAO: Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue (clinicaltrials.gov) - Feb 14, 2013
P3, N=50, Recruiting, Sponsor: Bjorn H. Ebdrup
- Enrollment change: The Effects of Work Schedule and Sleep Patterns on Caregivers' Health (clinicaltrials.gov) - Feb 13, 2013
P=N/A, N=211, Completed, Sponsor: Oregon Health and Science University
Active, not recruiting --> Completed N=900 --> 211
- Trial completion: The Effects of Work Schedule and Sleep Patterns on Caregivers' Health (clinicaltrials.gov) - Feb 13, 2013
P=N/A, N=211, Completed, Sponsor: Oregon Health and Science University
N=900 --> 211 Not yet recruiting --> Completed
- Tredaptive (niacin controlled release/laropiprant) / Merck (MSD)
Trial termination: Effect of Niacin/Laropiprant on Postprandial Lipoprotein Metabolism in Patients With Dyslipoproteinemia (clinicaltrials.gov) - Feb 11, 2013
P4, N=12, Terminated, Sponsor: Ludwig-Maximilians - University of Munich
Not yet recruiting --> Completed Active, not recruiting --> Terminated; negative endpoint study resulting in withdrawal of study drug
- ||||| atorvastatin / Generic mfg.
New P1/2 trial: Prothrombotic Inflammatory Markers in Women With Metabolic Syndrome - Effect of Atorvastatin (clinicaltrials.gov) - Feb 5, 2013
P1/2, N=88, Active, not recruiting, Sponsor: University of Rochester
- Daliresp (roflumilast) / AstraZeneca, Takeda, AbbVie
Enrollment open: RAMBO: Impact of Roflumilast on Visceral Adiposity and Metabolic Profile in Chronic Obstructive Pulmonary Disease (clinicaltrials.gov) - Feb 3, 2013
P2, N=122, Recruiting, Sponsor: Laval University
Active, not recruiting --> Terminated; negative endpoint study resulting in withdrawal of study drug Not yet recruiting --> Recruiting
- Enrollment open: Oral Nitrite in Adults With Metabolic Syndrome and Hypertension (clinicaltrials.gov) - Jan 29, 2013
P2, N=20, Recruiting, Sponsor: University of Pittsburgh
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- Enrollment change: Effects From a Mandibular Repositioning Appliance in Patients With Obstructive Sleep Apnea and Snoring (clinicaltrials.gov) - Jan 16, 2013
P=N/A, N=96, Completed, Sponsor: Ume
Not yet recruiting --> Recruiting N=200 --> 96
- Trial completion: Effects From a Mandibular Repositioning Appliance in Patients With Obstructive Sleep Apnea and Snoring (clinicaltrials.gov) - Jan 16, 2013
P=N/A, N=96, Completed, Sponsor: Ume
N=200 --> 96 Recruiting --> Completed
- Enrollment change: Inofolic NRT and the Metabolic Syndrome (clinicaltrials.gov) - Jan 14, 2013
P=N/A, N=80, Completed, Sponsor: University of Messina
Recruiting --> Completed N=120 --> 80
- Trial completion: Inofolic NRT and the Metabolic Syndrome (clinicaltrials.gov) - Jan 14, 2013
P=N/A, N=80, Completed, Sponsor: University of Messina
N=120 --> 80 Recruiting --> Completed
- Enrollment open, Surgery: Prospective Cohort Study for Analyzing the Effect of Gastric Cancer Surgery to the Metabolic Syndrome and Insulin Resistance (clinicaltrials.gov) - Jan 12, 2013
P=N/A, N=270, Recruiting, Sponsor: Yonsei University
Recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment closed: MUFA PUFA: Comparative Effects of 2 Diets in Veterans With the Metabolic Syndrome (clinicaltrials.gov) - Jan 9, 2013
P=N/A, N=70, Active, not recruiting, Sponsor: Department of Veterans Affairs
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- | Victoza (liraglutide) / Novo Nordisk
New P4 trial: MAGNA VICTORIA: Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients (clinicaltrials.gov) - Jan 2, 2013
P4, N=50, Recruiting, Sponsor: Leiden University Medical Center
- Trial completion: Soy Protein Intake and the Metabolic Syndrome (clinicaltrials.gov) - Jan 2, 2013
P=N/A, N=15, Completed, Sponsor: Wageningen University
Recruiting --> Active, not recruiting Not yet recruiting --> Completed
- Trial completion: Dairy Lipids, Proteins, and the Metabolic Syndrome - "DairyHealth" (clinicaltrials.gov) - Jan 2, 2013
P=N/A, N=63, Completed, Sponsor: University of Aarhus
Not yet recruiting --> Completed Recruiting --> Completed